The rate of nonfounder BRCA1/2 mutations in AJ patients tested for HBOC is similar to that reported by Walsh et al.15 Walsh et al reported that 0.8% of full AJ patients with a diagnosis of breast cancer carried a nonfounder BRCA1/2 variant. This evidence concerns the gene BRCA1 and breast cancer.